Genetic switch may be key to increased lifespan

Image
Press Trust of India Los Angeles
Last Updated : May 03 2016 | 4:57 PM IST
Scientists have discovered genetic switches in worms that are also linked to increased lifespan in mammals and may be targeted by drugs to improve human metabolic function and increase longevity.
These epigenetic switches, discovered by scientists at the University of California, Berkeley, and the Ecole Polytechnique Federale de Lausanne in Switzerland, are enzymes that are ramped up after mild stress during early development and continue to affect the expression of genes throughout the animal's life.
When researchers looked at strains of inbred mice that have radically different lifespans, they found that those with the longest lifespans had significantly higher expression of these enzymes than the short-lived mice.
"Two of the enzymes we discovered are highly correlated with lifespan; it is the biggest genetic correlation that has ever been found for lifespan in mice, and they are both naturally occurring variants," said Andrew Dillin from the University of California, Berkeley.
"Based on what we see in worms, boosting these enzymes could reprogramme your metabolism to create better health, with a possible side effect of altering lifespan," said Dillin.
These are the first epigenetic modifiers known to affect metabolic function and longevity, though others are known to affect either metabolism or lifespan, researchers said.
For decades, researchers have found correlations between nutrient availability during early development and adult health and metabolism.
Brief changes in the energy available to the cell - caused by restricting diet, for example - seem to reshape animal physiology for years to come, even affecting lifespan.
These observations led to the idea that reducing cellular energy production could slow the ageing process and make organisms live longer.
These energy restrictions had to occur during a specific window of development in order to affect the ageing process, suggesting the existence of a critical metabolic switch that could remodel cellular functions throughout the organism's entire lifespan, researchers said.
They focused their search on the power factory of the cell, the mitochondria.
Malfunctioning mitochondria have been reported as a cause or a consequence of nearly every single age-onset human disease, including Alzheimer's and Parkinson's disease, heart disease, type 2 diabetes and cancer, said Dillin.
The findings were published in the journal Cell.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 03 2016 | 4:57 PM IST

Next Story